Disc Medicine Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disc medicine company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disc Medicine Company Profile Today - Breaking & Trending Today

Disc Medicine (NASDAQ:IRON) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $85.00 price objective on the stock. Several other equities research analysts also recently commented on the company. Morgan Stanley reduced their target price on Disc […] ....

United States , Raymond James , Stifel Nicolaus , William Richard White , Charles Schwab Investment Management Inc , Morgan Stanley , Disc Medicine Company Profile , York Mellon Corp , Barclays Plc , Disc Medicine Inc , Cantor Fitzgerald , Swiss National Bank , Victory Capital Management Inc , Disc Medicine , Free Report , Moderate Buy , Medicine Stock Down , Get Free Report , Director William Richard White , New York Mellon Corp , Capital Management , National Bank , Charles Schwab Investment Management , Schwab Investment Management , Disc Medicine Daily ,

Disc Medicine's (IRON) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $85.00 target price on the stock. IRON has been the subject of a number of other reports. Wedbush reaffirmed an outperform rating and set a $43.00 price […] ....

United States , Raymond James , William Richard White , Stifel Nicolaus , Jennison Associates , Disc Medicine Company Profile , Victory Capital Management Inc , Cantor Fitzgerald , Pricet Rowe Associates Inc , Disc Medicine Inc , First Turn Management , Disc Medicine , Free Report , Moderate Buy , Get Free Report , Director William Richard White , Turn Management , Capital Partners , Victory Capital Management , Disc Medicine Daily ,

Insider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 2,560 Shares of Stock

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) Director William Richard White sold 2,560 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was sold at an average price of $31.80, for a total value of $81,408.00. The transaction was disclosed in a document filed with the SEC, […] ....

United States , Stifel Nicolaus , William Richard White , Disc Medicine Company Profile , Morgan Stanley , Disc Medicine Inc , Steward Partners Investment Advisory , Ameritas Investment Partners Inc , Deutsche Bank , Cantor Fitzgerald , Disc Medicine , Get Free Report , Director William Richard White , Partners Investment Advisory , Investment Partners , Disc Medicine Daily ,

Disc Medicine's (IRON) Outperform Rating Reiterated at Wedbush

Wedbush restated their outperform rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report released on Monday morning, RTT News reports. The brokerage currently has a $43.00 target price on the stock, down from their prior target price of $84.00. Wedbush also issued estimates for Disc Medicine’s Q4 2024 earnings at […] ....

United States , Kevin Bitterman , Raymond James , Ameritas Investment Partners Inc , Venture Fund Xlp Atlas , America Corp , Disc Medicine Inc , Cantor Fitzgerald , Steward Partners Investment Advisory , Disc Medicine Company Profile , Securities Exchange Commission , Morgan Stanley , Disc Medicine , Free Report , Moderate Buy , Medicine Trading Down , Get Free Report , Director Kevin Bitterman , Exchange Commission , Venture Fund , Investment Partners , Partners Investment Advisory , Disc Medicine Daily , Nasdaq Iron , Reiterated Rating ,

Disc Medicine's (IRON) "Outperform" Rating Reiterated at Raymond James

Raymond James restated their outperform rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report sent to investors on Monday, MarketBeat Ratings reports. Raymond James currently has a $40.00 target price on the stock, down from their prior target price of $75.00. IRON has been the subject of several other reports. […] ....

Kevin Bitterman , Raymond James , Steward Partners Investment Advisory , Securities Exchange Commission , Ameritas Investment Partners Inc , Venture Fund Xlp Atlas , Cantor Fitzgerald , Disc Medicine Inc , Morgan Stanley , Tower Research Capital , Disc Medicine Company Profile , Disc Medicine , Free Report , Marketbeat Ratings , Moderate Buy , Get Free Report , Director Kevin Bitterman , Venture Fund , Exchange Commission , Partners Investment Advisory , Investment Partners , Research Capital , Disc Medicine Daily , Nasdaq Iron , Reiterated Rating ,